Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11826408
CD200 inhibitors and methods of use thereof
granted -
US 11819512
Solid forms of a CD73 inhibitor and the use thereof
granted -
US 11820982
Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors
granted -
US 11820775
Pyrrolopyrimidine ITK inhibitors
granted -
US 11813257
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
granted -
US 11813267
DNA-PK inhibitors
granted -
US 11814377
Pyrimidine compound as JAK kinase inhibitor
granted -
US 11807649
Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2
granted -
US 11807658
CD73 inhibitors
granted -
US 11807646
4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)
granted -
US 11807605
Human plasma kallikrein inhibitors
granted -
US 11802110
2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase
granted -
US 11795180
Formulation of a pan-JAK inhibitor
granted -
US 11793855
TFPI inhibitors and methods of use
granted -
US 11787796
Plasma Kallikrein inhibitors and uses thereof
granted -
US 11786500
Glutaminase inhibitor therapy
granted -
US 11786517
Methods of treatment using a JAK inhibitor compound
granted -
US 11786541
Inhibitor of sphingosine kinase 2 for treating Ebola
granted -
US 11787762
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
granted -
US 11780837
CXCR4 inhibitors and uses thereof
granted -
US 11780821
Inhibitors of fibroblast activation protein
granted -
US 11780845
FGFR inhibitors and methods of use thereof
granted -
US 11773393
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted -
US 11767526
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted